RaQualia Pharma Inc 4579.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
749.00quote price arrow up+6.00 (+0.81%)
Volume
97,200
52 week range
714.00 - 1,349.00
Loading...
  • Open743.00
  • Day High760.00
  • Day Low743.00
  • Prev Close743.00
  • 52 Week High1,349.00
  • 52 Week High Date12/23/21
  • 52 Week Low714.00
  • 52 Week Low Date05/10/22

Key Stats

  • Market Cap124.25M
  • Shares Out20.96M
  • 10 Day Average Volume198,610
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-36.2

KEY STATS

  • Open743.00
  • Day High760.00
  • Day Low743.00
  • Prev Close743.00
  • 52 Week High1,349.00
  • 52 Week High Date12/23/21
  • 52 Week Low714.00
  • 52 Week Low Date05/10/22
  • Market Cap124.25M
  • Shares Out20.96M
  • 10 Day Average Volume198,610
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-36.2

RATIOS/PROFITABILITY

  • EPS (TTM)16.20
  • P/E (TTM)46.23
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On RaQualia Pharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
RaQualia Pharma Inc. is a Japan-based company engaged in the research and development of pharmaceutical products. The Company is mainly engaged in the discovery and research, the preclinical trials and part of clinical trials of drugs, as well as the licensing of developed compounds to pharmaceutical companies. The Company is focused on pain diseases area and intestinal disease area. Its products include EP4 antagonist, cyclooxygenase-2 (COX-2) inhibitory, 5-HT4 portion...
Address
8F, Daiwa Meieki Bldg.
1-21-19, Meieki-Minami
Nakamura-ku
Nagoya-shi, ACH
450-0003
Japan